Georges Dagher, senior investigator (Directeur de Recherche) at Inserm (Paris, France) accomplished most of his career in pathophysiological and clinical research at Necker Hospital (1979-1984), College de France (1985-1993) and Faculty of medicine Broussais-Hotel Dieu (1994-2004). He joined the physiological laboratory (Cambridge, UK) for a post-doc fellowship (1983-85) and was a special guest to physiological laboratory, Harvard Medical School (Boston, US, 1982, 1984). Georges Dagher published about 100 papers in international peer-reviewed journals on hypertension, arterial hypertrophy, obesity and lipid metabolism, manic depression, renal physiology, and transmembrane ion transport. He was the director of BIOBANQUES infrastructure (Inserm US 13), a French infrastructure that regroups 85 biobanks (2012-2017); the coordinator of biological resources centres at Inserm (2006); the director of clinical research infrastructures at Inserm (2006-2009) and the deputy director of the department of clinical research at the Public Health Institute, Inserm, France (2009-2011). He participated actively to the preparatory phase of the pan-European Biobanking and Biomolecular Research Infrastructure (BBMRI-ERIC). In this preparatory phase he was a leading figure of the coordination committee and the leader of a work package on funding and financing. Later, when the infrastructure was set up as an ERIC, he was the vice chair of the Assembly of Members and member of the coordination body. He is also a member of BIOSHARE and BBMRI- LPS within the 7th EU framework program. He contributed to the OECD best practice guidelines for biological resource centres and the OECD guidelines on human biobanks and genetic databases.
He participated in the elaboration of the French norm for biobanks NF S96-900 norm and the convenor of an ISO committee drafting an international standard for biobanking. He is a delegate of several French institutions to European and international committees or meetings (OECD, ESF, ERA, ALLEA, EASAC…) and a number of expert committees focusing on the issues related to biobanks within Europe and internationally. He is an expert to the Austrian Federal Ministry of science and research (BMWF) and Genome Quebec. He was also a member of the Inserm ethics committee (ERMES) and the Institutional Review Board (IRB).